| 标题 |
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Rodney Dawson; Andreas H Diacon; Daniel Everitt; Christo van Niekerk; Peter R Donald; et al 出版日期:2015 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)